News for hackers. Stuff that matters.
Re:When the Patient Is a Gold Mine: The Trouble with Rare-Di... by eganist on Thursday May 25, 2017 @07:44AM (#14416698)
Sunk costs on failed treatments, generally. I don't remember the stat well enough, but it's something like a double-digit quantity of candidates fail for each single one that receives FDA approval.

Here's hoping someone else can investigate and share the exact number. I'm at a stoplight.

There are no comments on this comment yet.